Increased risk for anxiety may begin before birth, shaped by infection or stressful events during pregnancy, according to a new preclinical study from researchers at Weill Cornell Medicine. While scientists have long known that maternal difficulty during pregnancy may raise a child’s risk for psychiatric illness, the biological pathways between these prenatal experiences and later mental health have been unclear.
Cancer Progression Illuminated by New Multi-Omics Tool
October 31, 2025
Friday, October 10, 2025
A new tool developed by Weill Cornell Medicine and the University of Adelaide investigators has enhanced the ability to track multiple gene mutations while simultaneously recording gene activity in individual cancer cells.
Study Finds Restoring Order to Dividing Cancer Cells May Prevent Metastasis
October 31, 2025
Friday, October 3, 2025
Triple negative breast cancer (TNBC) is one of the most aggressive and hardest to treat breast cancers, but a new study led by Weill Cornell Medicine suggests a way to stop it from spreading. Researchers have discovered that an enzyme called EZH2 drives TNBC cells to divide abnormally, which enables them to relocate to distant organs.
Galvanizing Blood Vessel Cells to Expand for Organ Transplantation
October 16, 2025
Scientists have discovered a method to induce human endothelial cells from a small biopsy sample to multiply in the laboratory, producing more than enough cells to replace damaged blood vessels or nourish organs for transplantation, according to a preclinical study by Weill Cornell Medicine investigators. Endothelial cells form the inner lining of blood vessels and regulate blood flow, inflammation and healing. Traditional approaches for growing these cells in the lab have yielded only limited numbers before they lose their ability to function.
Research at Risk: Rooting out treatment-resistant prostate cancer
October 7, 2025
Advances in prostate cancer early detection and treatment have improved outcomes in men diagnosed with the disease. Yet doctors and scientists have long been vexed by a question: Why do most men whose prostate cancer initially responds to hormonal-blocking therapy later develop a lethal, treatment-resistant form of the disease?
EIPM's 3Q External Newsletter
October 5, 2025
Welcome to third quarterly external newsletter of 2025!
Fischbach-Teschl to lead Engineering Innovations in Medicine initiative
September 25, 2025
Engineering Innovations in Medicine, an initiative launched by Cornell Engineering and Weill Cornell Medicine in 2022 to transform human health through data-driven innovation and interdisciplinary collaboration, will now be led by Claudia Fischbach-Teschl as part of her portfolio as James M. and Marsha McCormick Family Director of the Meinig School of Biomedical Engineering.
September 2025 EIPM Director's Memo
September 5, 2025
Dear Friends & Members of the Englander Institute,
I hope you enjoy reading about our recent departmental accomplishments, including news media coverage of our work, interesting & engaging departmental events, and impressive publications in top-tier journals like Nature Biotechnology.
August 2025 EIPM Director's Monthly Memo
August 6, 2025
August 2025 EIPM Director's Memo
Dear Friends & Members of the Englander Institute,
As I shared in the most recent EIPM Weekly News Roundup newsletter, I've always taken the most pride in the high-quality research our colleagues have published in leading peer-reviewed journals. But July was truly something special, with outstanding papers (below) by dozens of our team members. Congratulations to everyone who contributed to the outstanding work!
Uncovering How a Molecule Responsible for Immune “Brakes” Directs Skin Defenses
August 1, 2025
Weill Cornell Medicine researchers have discovered that PD-1—a molecule best known for putting the brakes on immune cells—also plays a critical role in helping T cells become long-term immune defenders in the skin. Early during infection, PD-1 acts like a steering wheel, guiding T cells to become protective resident memory T cells (TRM) that stay in place. These cells remember invading germs or cancer and quickly mount a response if that enemy reappears.